Dry eye syndrome (DES), also called dry eye disease (DED) or by its clinical Latin name keratoconjunctivitis sicca (KCS), is a multifactorial disease of the ocular surface caused by loss of tear film homeostasis — the complex three-layer structure of lipid, aqueous, and mucin that coats, lubricates, and protects the corneal and conjunctival epithelium with every blink. The condition produces a self-perpetuating cycle: inadequate or unstable tear film → ocular surface desiccation and inflammation → nerve damage → further tear dysfunction. DES is broadly classified into two overlapping pathophysiologic subtypes: aqueous-deficient dry eye (ADDE) — failure of the lacrimal gland to produce sufficient aqueous tear volume (the H04.12x code family), most severely seen in Sjögren’s syndrome (M35.01); and evaporative dry eye (EDE) — accelerated tear evaporation due to meibomian gland dysfunction (MGD), the most common subtype, where inadequate lipid secretion destabilizes the tear film despite adequate aqueous production. The Tear Film & Ocular Surface Society (TFOS) DEWS II report (2017) established the current gold-standard staged severity grading system: Stage 1 (mild, responds to artificial tears) → Stage 2 (moderate, requires Rx therapy) → Stage 3 (severe, requires office-based intervention) → Stage 4 (very severe, sight-threatening; amniotic membrane). For AAPC-certified ophthalmology profee coders, dry eye coding requires critical distinctions between the H04.12x (aqueous tear deficiency/tear film insufficiency) and H16.22x (keratoconjunctivitis sicca) code families — these are not interchangeable and map to different clinical scenarios. Additionally, the treatment procedures for dry eye span a wide CPT range from simple punctal occlusion (68761) to advanced thermal pulsation (0207T) and amniotic membrane application (65778) — each with distinct coverage criteria, LCD requirements, and modifier patterns.
Applied to the cornea for its tough, horn-like quality; root of keratitis (corneal inflammation), keratotomy (corneal incision), keratin (structural protein)
Latin conjunctīva (sc. tunica) — “connecting membrane”; from conjungere — “to join together”
Named by Renaissance anatomists for the continuous membrane connecting the inner eyelids to the anterior globe surface; con- (together) + jungere (to yoke, join)
Used in keratoconjunctivitis sicca as a modifying adjective meaning “dry”; also root of desiccation, siccative; cognate with Greek iskhein (“to hold back”)
The full clinical term keratoconjunctivitis sicca was coined in 1933 by Swedish ophthalmologist Henrik Sjögren in his landmark doctoral thesis describing a triad of dry eyes, dry mouth, and arthritis — the autoimmune condition that now bears his name. Sjögren used the Latin adjective sicca to distinguish desiccating ocular inflammation from the more general keratoconjunctivitis seen in viral and allergic etiologies. The root kéras (Greek: “horn”) was applied to the cornea since antiquity — the cornea’s avascular, structurally rigid quality reminded early anatomists of horn or fingernail material. The informal English compound “dry eye” entered widespread clinical use in the mid-20th century, gaining traction as the condition was recognized beyond Sjögren’s cases to include the broader aging, environmental, and MGD-driven etiologies that dominate clinical practice today. The modern preferred clinical designation has shifted from “dry eye syndrome” to “dry eye disease” (DED) in research literature (TFOS DEWS II, 2017) to emphasize its chronic, progressive disease nature — though ICD-10-CM still uses the descriptor dry eye syndrome in its official H04.12 code description.
🔀 ALIASES / ALTERNATE TERMS
Term
Relationship
Dry eye disease (DED)
Current preferred research/clinical term (TFOS DEWS II 2017); same ICD-10 codes as DES
Keratoconjunctivitis sicca (KCS)
Latin clinical term; more severe spectrum involving corneal changes; coded H16.221-H16.229 when not Sjögren’s related
Tear film insufficiency
ICD-10-CM “includes” note under H04.12x — if provider documents this term, use H04.12x family
Subtype: meibomian gland dysfunction; most common DES type; same H04.12x codes unless corneal involvement present
Meibomian gland dysfunction (MGD)
Primary cause of evaporative DES; no separate ICD-10 code — coded under H04.12x or H16.22x depending on severity
Sjögren’s syndrome KCS
Autoimmune; coded M35.01 — do NOT use H04.12x or H16.22x when Sjögren’s is the documented etiology; M35.01 includes the keratoconjunctivitis
Sicca syndrome
Older term for Sjögren’s-related dry eye/dry mouth complex; coded M35.01 when Sjögren’s documented
Filamentary keratitis
Complication of severe DES; mucous filaments adherent to corneal surface; coded H16.121-H16.129
Neurotrophic keratitis
Corneal desensitization from severe DES or prior herpetic disease; coded H16.231-H16.239; may require amniotic membrane treatment
🔗 RELATED TERMS
Tear film — three-layer structure (outer lipid/meibomian layer, middle aqueous/lacrimal layer, inner mucin/goblet cell layer); disruption of any layer causes DES; the lipid layer is assessed by TBUT (tear break-up time)
Meibomian glands — modified sebaceous glands in the tarsal plates of upper and lower lids (~25-30 per lid); secrete lipid layer of tear film; their dysfunction (MGD) is the leading cause of evaporative DES; assessed by lid margin examination, meibography
Lacrimal gland — produces the aqueous tear layer; failure = aqueous deficient DES; most severe in Sjögren’s syndrome; assessed by Schirmer’s test
Goblet cells — mucin-secreting cells of the conjunctival epithelium; produce the mucin layer that anchors the tear film to the ocular surface; reduced in vitamin A deficiency and cicatricial conjunctival diseases
Sjögren’s syndrome — autoimmune exocrinopathy destroying lacrimal and salivary glands; most severe ADDE etiology; coded M35.01 (primary) — excludes H04.12x and H16.22x by their own Excludes1 note
Punctal plug — silicone or collagen device inserted into lacrimal punctum to reduce tear drainage and retain tear volume; CPT 68761; requires conservative therapy trial documentation per payer LCD
LipiFlow / TearCare — thermal pulsation devices heating and evacuating meibomian glands; CPT 0207T (Category III); coverage limited — Medicare does not currently reimburse; verify payer by policy
Intense pulsed light (IPL) — light-based treatment targeting abnormal telangiectasias of the lid margin, reducing meibomian gland inflammation; no dedicated CPT — reported as 17999 (unlisted) or 0563T with payer verification
Cyclosporine ophthalmic (Restasis/Cequa) — prescription anti-inflammatory eye drop; first-line Rx therapy for moderate DES; reduces T-cell mediated lacrimal inflammation; not separately CPT-billable — managed via E/M
Lifitegrast (Xiidra) — LFA-1 antagonist Rx eye drop; second major Rx dry eye therapy; same billing approach as cyclosporine
Amniotic membrane (Prokera/BioTissue) — self-retaining biologic ocular surface device; used for DEWS Stage 3-4; CPT 65778 (without sutures); requires documented failure of ≥4 weeks conservative therapy per LCD
Schirmer’s test — diagnostic strip test measuring aqueous tear production; no separate CPT — included in comprehensive eye exam (92004/92014) documentation
TBUT (Tear Break-Up Time) — fluorescein staining measurement of tear film stability; short TBUT = evaporative dry eye; no separate CPT — included in exam E/M
Corneal staining — fluorescein or rose bengal/lissamine green staining to assess epithelial damage from DES; graded with Oxford or CCLRU scales; supports medical necessity documentation; included in comprehensive exam
Blepharitis — eyelid margin inflammation; strongly associated with and perpetuates MGD-driven DES; coded by type — anterior (H01.001-H01.009) or posterior (seborrheic/meibomian); code both when concurrent with DES
CODING CORNER
📋 ICD-10-CM — Dry Eye Syndrome
⚠️ TWO SEPARATE DES CODE FAMILIES EXIST AND ARE NOT INTERCHANGEABLE: H04.12x = Dry eye syndrome / tear film insufficiency (aqueous deficient subtype, lacrimal gland based); H16.22x = Keratoconjunctivitis sicca (more severe spectrum with corneal involvement, non-Sjögren’s). When Sjögren’s syndrome is the documented etiology, use M35.01 ONLY — H04.12x and H16.22x each have Excludes1 notes for Sjögren’s. Parent codes H04.12 and H16.22 are NOT billable — laterality character required. Do NOT default to unspecified (H04.129, H16.229) when laterality is documented.
Keratoconjunctivitis sicca, not specified as Sjögren’s, right eye (more severe DES with corneal desiccation/staining; Excludes1: Sjögren’s → use M35.01)
Sjögren syndrome with keratoconjunctivitis (primary Sjögren’s with dry eye — do NOT additionally code H04.12x or H16.22x; M35.01 is complete; Excludes1 in both H04.12 and H16.22)
⚠️ Schirmer’s test, TBUT, and corneal staining are NOT separately billable CPT services — they are included in the comprehensive eye exam (92004/92014) or E/M visit and cannot be billed as standalone codes. CPT 0207T (LipiFlow/TearCare thermal pulsation) is a Category III code — Medicare does NOT reimburse; most commercial payers also do not cover; verify payer-by-payer before billing. CPT 65778 (amniotic membrane) requires documented Stage 3-4 severity and failure of ≥4 weeks conservative therapy per Medicare LCD.
Eye Examination E/M — Foundation of DES Management
Ophthalmological services; new patient, comprehensive (new patient complete DES workup including anterior segment, Schirmer, staining — all within exam)
Closure of lacrimal punctum; by plug, each (punctal plug insertion — billed per punctum; commonly 2-4 plugs per session; modifiers -E1 through -E4 required for each punctum treated)
Dilation of lacrimal punctum, with or without irrigation (preparatory dilation before plug placement — check NCCI; may bundle with 68761 same punctum same day)
Meibomian Gland Treatments
CPT Code
Description
0207T
Evacuation of meibomian glands, automated, using heat and pressure (LipiFlow, TearCare — Category III; verify payer coverage before billing; Medicare non-covered)
0563T
Evacuation of meibomian glands using heat delivered by device, per treatment session (alternative Category III for thermal treatments including some IPL systems; payer coverage highly variable)
Unlisted procedure, skin, mucous membrane and subcutaneous tissue (used for IPL [intense pulsed light] dry eye treatment when no specific CPT applies; requires special report; payer specific)
External ocular photography with interpretation and report; for documentation of medical progress (anterior segment photography documenting corneal staining severity — supports medical necessity for advanced DES treatments)
Bilateral — bilateral amniotic membrane placement (65778) or bilateral thermal pulsation (0207T) at same session; note: 68761 is typically billed per punctum with -E1 through -E4 rather than -50
Upper left eyelid punctum — critical for punctal plug billing; 68761 is billed per individual punctum and -E1 through -E4 identify which punctum was treated
Distinct procedural service — e.g., 68761 (punctal plug) performed at distinct session from E/M; or 92285 (photography) distinct from exam on same day with appropriate documentation
Significant, separately identifiable E/M on same day as procedure — append to 92012/92014 or 99213/99214 when a separately documented E/M is performed on the same day as 68761 punctal plug insertion; requires distinct documentation
Unplanned return to OR within global period — e.g., plug loss/replacement (68761) or amniotic membrane replacement (65778) within 10-day global of original placement
⚠️ Coding Notes & Payer Guidance
H04.12x vs. H16.22x — which code when: The two code families describe a clinical continuum rather than completely distinct conditions. Broadly: H04.12x is appropriate when the provider documents “dry eye syndrome,” “tear film insufficiency,” or aqueous deficiency without specific documentation of corneal involvement or staining. H16.22x is appropriate when the provider specifically documents keratoconjunctivitis sicca, corneal desiccation, or positive corneal fluorescein/rose bengal staining indicating epithelial damage. In practice, the provider’s documentation language drives selection — do not upgrade from H04.12x to H16.22x without documented corneal findings.
M35.01 — the Sjögren’s Excludes1 trap: Both H04.12 and H16.22 carry Excludes1 notes for Sjögren’s syndrome (M35.01). An Excludes1 note means the two codes cannot be billed together on the same claim for the same condition. When the provider documents Sjögren’s as the etiology of the dry eye, use M35.01 only — it includes the keratoconjunctivitis. CodingH04.123 and M35.01 together on the same claim for the same patient encounter violates the Excludes1 rule and will generate an edit.
Punctal plug modifier pattern — -E modifiers are mandatory: CPT 68761 is defined as closure of a single lacrimal punctum. When multiple plugs are placed (e.g., both lower puncta), 68761 is billed on a separate line for each punctum, each with its specific -E modifier (-E2 for lower left, -E4 for lower right). Billing a single 68761 with modifier -50 for bilateral lower puncta is a common error — the correct approach is two separate 68761 lines with -E2 and -E4 respectively. Some payers may require -LT/-RT in addition to or instead of -E modifiers — verify payer-specific billing guidelines.
Modifier -25 for same-day E/M and punctal plug: When a provider performs a significant separately identifiable evaluation and management service on the same day as punctal plug insertion (68761), modifier -25 must be appended to the E/M code (not the procedure code). The documentation must clearly support both the procedural decision and the E/M service as separate and distinct components of the visit — a single note that only addresses the plug placement does not support -25.
0207T, 0563T, and 17999 — coverage reality check: Thermal pulsation (LipiFlow, TearCare) and IPL represent the highest out-of-pocket DES procedures. Category III codes 0207T and 0563T should only be submitted to payers with confirmed coverage policies. Medicare currently does not reimburse Category III codes for these procedures. 17999 (unlisted) for IPL always requires a special report and is subject to payer discretion — it is common practice but not guaranteed reimbursement.
65778 amniotic membrane documentation requirements: CPT 65778 (Prokera or equivalent self-retaining amniotic membrane) for severe DES requires documented evidence of: (1) DEWS Stage 3 or Stage 4 severity; (2) failed ≥4 weeks of conservative therapy including preservative-free artificial tears QID, Restasis or Xiidra, and punctal plugs; (3) corneal staining consistent with epithelial damage. Missing any of these documentation elements is the primary cause of 65778 denials for dry eye. Note: V2790 (amniotic membrane supply code) is included in the Medicare allowance for 65778 and 65779 — do NOT separately bill V2790 on Medicare claims for these procedures.
Crystal's MCW Coder Hub